Aminobenzoic Acid
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB02362 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 72 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hereditary angioedema with C1Inh deficiency | KG + DL |
| 2 | C1 inhibitor deficiency | KG + DL |
| 3 | serpinopathy with toxic serpin polymerization | KG + DL |
| 4 | Camurati-Engelmann disease | KG + DL |
| 5 | posterior leukoencephalopathy syndrome | KG + DL |
| 6 | limited systemic sclerosis | KG + DL |
| 7 | geleophysic dysplasia | KG + DL |
| 8 | aortic valve insufficiency | KG + DL |
| 9 | carcinosarcoma | KG + DL |
| 10 | pseudoxanthoma elasticum, forme fruste | KG + DL |
| 11 | IgA nephropathy, susceptibility to | KG + DL |
| 12 | IgA glomerulonephritis | KG + DL |
| 13 | nephrosclerosis | KG + DL |
| 14 | elastoma | KG + DL |
| 15 | diffuse cutaneous systemic sclerosis | KG + DL |
| 16 | immune-mediated necrotizing myopathy | KG + DL |
| 17 | antisynthetase syndrome | KG + DL |
| 18 | focal myositis | KG + DL |
| 19 | infantile digital fibromatosis | KG + DL |
| 20 | inflammatory myopathy with abundant macrophages | KG + DL |
| 21 | idiopathic eosinophilic myositis | KG + DL |
| 22 | Ledderhose disease | KG + DL |
| 23 | palmar fibromatosis | KG + DL |
| 24 | peeling skin syndrome | KG + DL |
| 25 | papillomatosis | KG + DL |
| 26 | hereditary angioedema | KG + DL |
| 27 | papilloma | KG + DL |
| 28 | squamous papilloma | KG + DL |
| 29 | occupational asthma | KG + DL |
| 30 | balanoposthitis | KG + DL |
| 31 | limited cutaneous systemic sclerosis | KG + DL |
| 32 | pseudo-von Willebrand disease | KG + DL |
| 33 | primary release disorder of platelets | KG + DL |
| 34 | pemphigus vegetans | KG + DL |
| 35 | familial Dupuytren contracture | KG + DL |
| 36 | selective IgG immunodeficiency | KG + DL |
| 37 | recurrent infections associated with rare immunoglobulin isotypes deficiency | KG + DL |
| 38 | myasthenia, limb-girdle, autoimmune | KG + DL |
| 39 | myasthenia gravis with thymus hyperplasia | KG + DL |
| 40 | linear scleroderma | KG + DL |
| 41 | neonatal myasthenia gravis | KG + DL |
| 42 | disease of receptor activity | KG + DL |
| 43 | autoimmune disease of peripheral nervous system | KG + DL |
| 44 | adult-onset myasthenia gravis | KG + DL |
| 45 | complement component C1s deficiency | KG + DL |
| 46 | focal segmental glomerulosclerosis | KG + DL |
| 47 | congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization | KG + DL |
| 48 | inflammatory bowel disease, immunodeficiency, and encephalopathy | KG + DL |
| 49 | immunotactoid or fibrillary glomerulopathy | KG + DL |
| 50 | selective IgG subclass deficiency | KG + DL |
(Showing top 50 of 72 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.